44 related articles for article (PubMed ID: 23441080)
1. Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.
Stahl M; Giblin G; Liu Y; Winer ES; Garcia JS; Chen E; Wadleigh M; Ling K; Lindsley RC; Shimony S; Copson K; Charles A; DeAngelo DJ; Stone RM; Nohria A; Luskin MR
Leuk Res; 2023 Sep; 132():107351. PubMed ID: 37451200
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy.
Leger KJ; Robison N; Narayan HK; Smith AM; Tsega T; Chung J; Daniels A; Chen Z; Englefield V; Demissei BG; Lefebvre B; Morrow G; Dizon I; Gerbing RB; Pabari R; Getz KD; Aplenc R; Pollard JA; Chow EJ; Tang WHW; Border WL; Sachdeva R; Alonzo TA; Kolb EA; Cooper TM; Ky B
Front Cardiovasc Med; 2023; 10():1286241. PubMed ID: 38107263
[TBL] [Abstract][Full Text] [Related]
3. CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.
Wang X; Sun CL; Quiñones-Lombraña A; Singh P; Landier W; Hageman L; Mather M; Rotter JI; Taylor KD; Chen YD; Armenian SH; Winick N; Ginsberg JP; Neglia JP; Oeffinger KC; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Bhatia S
J Clin Oncol; 2016 Mar; 34(8):863-70. PubMed ID: 26811534
[TBL] [Abstract][Full Text] [Related]
4. Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy.
Masood IR; Rezvan PH; Lee K; Vervaet H; Kuo C; Loss K; Menteer J; Souza A; Freyer D; Su JA
Pediatr Cardiol; 2023 May; ():1-10. PubMed ID: 37217803
[TBL] [Abstract][Full Text] [Related]
5. Inter-Individual Variation and Cardioprotection in Anthracycline-Induced Heart Failure.
Norton N; Weil RM; Advani PP
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575190
[TBL] [Abstract][Full Text] [Related]
6. Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia.
von Korn P; Vogt M; Oberhoffer R; Ewert P; Müller J
Cardiooncology; 2016 Oct; 2(1):8. PubMed ID: 33530145
[TBL] [Abstract][Full Text] [Related]
7. A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia.
Lappin KM; Davis L; Matchett KB; Ge Y; Mills KI; Blayney JK
Sci Rep; 2020 Oct; 10(1):18514. PubMed ID: 33116257
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
Cooper TM; Absalon MJ; Alonzo TA; Gerbing RB; Leger KJ; Hirsch BA; Pollard J; Razzouk BI; Aplenc R; Kolb EA
J Clin Oncol; 2020 Jul; 38(19):2170-2177. PubMed ID: 32401633
[TBL] [Abstract][Full Text] [Related]
9. The Epidemiological Trend of Acute Myeloid Leukemia in Childhood: a Population-Based Analysis.
Chen X; Pan J; Wang S; Hong S; Hong S; He S
J Cancer; 2019; 10(20):4824-4835. PubMed ID: 31598153
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group.
Getz KD; Sung L; Ky B; Gerbing RB; Leger KJ; Leahy AB; Sack L; Woods WG; Alonzo T; Gamis A; Aplenc R
J Clin Oncol; 2019 Jan; 37(1):12-21. PubMed ID: 30379624
[TBL] [Abstract][Full Text] [Related]
11. UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models.
DeRyckere D; Lee-Sherick AB; Huey MG; Hill AA; Tyner JW; Jacobsen KM; Page LS; Kirkpatrick GG; Eryildiz F; Montgomery SA; Zhang W; Wang X; Frye SV; Earp HS; Graham DK
Clin Cancer Res; 2017 Mar; 23(6):1481-1492. PubMed ID: 27649555
[No Abstract] [Full Text] [Related]
12. Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.
Lee-Sherick AB; Zhang W; Menachof KK; Hill AA; Rinella S; Kirkpatrick G; Page LS; Stashko MA; Jordan CT; Wei Q; Liu J; Zhang D; DeRyckere D; Wang X; Frye S; Earp HS; Graham DK
Oncotarget; 2015 Mar; 6(9):6722-36. PubMed ID: 25762638
[TBL] [Abstract][Full Text] [Related]
13. Global characteristics of childhood acute promyelocytic leukemia.
Zhang L; Samad A; Pombo-de-Oliveira MS; Scelo G; Smith MT; Feusner J; Wiemels JL; Metayer C
Blood Rev; 2015 Mar; 29(2):101-25. PubMed ID: 25445717
[TBL] [Abstract][Full Text] [Related]
14. Does this chest radiograph belong to a survivor of childhood cancer? Radiographic findings suggesting previous treatment for childhood cancer - a review.
Kumar AV; Kaste SC
J Am Osteopath Coll Radiol; 2014 Apr; 3(2):2-11. PubMed ID: 25328855
[TBL] [Abstract][Full Text] [Related]
15. Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.
Lipshultz SE; Diamond MB; Franco VI; Aggarwal S; Leger K; Santos MV; Sallan SE; Chow EJ
Paediatr Drugs; 2014 Oct; 16(5):373-89. PubMed ID: 25134924
[TBL] [Abstract][Full Text] [Related]
16. AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.
Cooper TM; Alonzo TA; Gerbing RB; Perentesis JP; Whitlock JA; Taub JW; Horton TM; Gamis AS; Meshinchi S; Loken MR; Razzouk BI
Cancer; 2014 Aug; 120(16):2482-9. PubMed ID: 24771494
[TBL] [Abstract][Full Text] [Related]
17. Treatment-related cardiotoxicity in survivors of childhood cancer.
Lipshultz SE; Cochran TR; Franco VI; Miller TL
Nat Rev Clin Oncol; 2013 Dec; 10(12):697-710. PubMed ID: 24165948
[TBL] [Abstract][Full Text] [Related]
18. Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective.
Orgel E; Zung L; Ji L; Finklestein J; Feusner J; Freyer DR
Pediatr Blood Cancer; 2013 Sep; 60(9):1528-33. PubMed ID: 23441080
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom.
Temming P; Qureshi A; Hardt J; Leiper AD; Levitt G; Ancliff PJ; Webb DK
Pediatr Blood Cancer; 2011 Apr; 56(4):625-30. PubMed ID: 21298750
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
